3,5-Diaryl-2-aminopyridines as a Novel Class of Orally Active Antimalarials Demonstrating Single Dose Cure in Mice and Clinical Candidate Potential

作者: Yassir Younis , Frederic Douelle , Tzu-Shean Feng , Diego González Cabrera , Claire Le Manach

DOI: 10.1021/JM3001373

关键词:

摘要: A novel class of orally active antimalarial 3,5-diaryl-2-aminopyridines has been identified from phenotypic whole cell high-throughput screening a commercially available SoftFocus kinase library. The compounds were evaluated in vitro for their antiplasmodial activity against K1 (chloroquine and drug-resistant strain) NF54 (chloroquine-susceptible as well cytotoxicity. Synthesis structure–activity studies number promising with selective activity. One these frontrunner compounds, 15, was equipotent across the two strains (K1 = 25.0 nM, 28.0 nM) superior to chloroquine strain IC50 194.0 nM). Compound 15 completely cured Plasmodium berghei-infected mice single oral dose 30 mg/kg. Dose–response generated ED50 ED90 values 0.83 1.74 mg/kg standard four-dose Peters test. Pharmacokinetic rat indicated that this compound good bioavailab...

参考文章(22)
Norio. Miyaura, Akira. Suzuki, Palladium-catalyzed cross-coupling reactions of organoboron compounds Chemical Reviews. ,vol. 95, pp. 2457- 2483 ,(1995) , 10.1021/CR00039A007
Yi Zhang, Olga A. Pavlova, Svetlana I. Chefer, Andrew W. Hall, Varughese Kurian, LaVerne L. Brown, Alane S. Kimes, Alexey G. Mukhin, Andrew G. Horti, 5-Substituted Derivatives of 6-Halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-Halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with Low Picomolar Affinity for α4β2 Nicotinic Acetylcholine Receptor and Wide Range of Lipophilicity: Potential Probes for Imaging with Positron Emission Tomography Journal of Medicinal Chemistry. ,vol. 47, pp. 2453- 2465 ,(2004) , 10.1021/JM030432V
Franco Lombardo, Marina Y. Shalaeva, Karl A. Tupper, Feng Gao, Elogdoct: a tool for lipophilicity determination in drug discovery basic and neutral compounds Journal of Medicinal Chemistry. ,vol. 44, pp. 2490- 2497 ,(2002) , 10.1021/JM0100990
Diego González Cabrera, Frederic Douelle, Tzu-Shean Feng, Aloysius T. Nchinda, Yassir Younis, Karen L. White, Quoc Wu, Eileen Ryan, Jeremy N. Burrows, David Waterson, Michael J. Witty, Sergio Wittlin, Susan A. Charman, Kelly Chibale, Novel orally active antimalarial thiazoles Journal of Medicinal Chemistry. ,vol. 54, pp. 7713- 7719 ,(2011) , 10.1021/JM201108K
A Andreani, 4-Aminopyridine derivatives with antiamnesic activity European Journal of Medicinal Chemistry. ,vol. 35, pp. 77- 82 ,(2000) , 10.1016/S0223-5234(00)00103-3
S. A. Charman, S. Arbe-Barnes, I. C. Bathurst, R. Brun, M. Campbell, W. N. Charman, F. C. K. Chiu, J. Chollet, J. C. Craft, D. J. Creek, Y. Dong, H. Matile, M. Maurer, J. Morizzi, T. Nguyen, P. Papastogiannidis, C. Scheurer, D. M. Shackleford, K. Sriraghavan, L. Stingelin, Y. Tang, H. Urwyler, X. Wang, K. L. White, S. Wittlin, L. Zhou, J. L. Vennerstrom, Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria Proceedings of the National Academy of Sciences of the United States of America. ,vol. 108, pp. 4400- 4405 ,(2011) , 10.1073/PNAS.1015762108
David Greenwood, Conflicts of interest: the genesis of synthetic antimalarial agents in peace and war Journal of Antimicrobial Chemotherapy. ,vol. 36, pp. 857- 872 ,(1995) , 10.1093/JAC/36.5.857
HM Louis, M Dror IBKevin, KD Ogobara, None, The pathogenic basis of malaria Nature. ,vol. 415, pp. 673- 679 ,(2002) , 10.1038/415673A
K. H. Rieckmann, The chequered history of malaria control: are new and better tools the ultimate answer? Annals of Tropical Medicine and Parasitology. ,vol. 100, pp. 647- 662 ,(2006) , 10.1179/136485906X112185